Trial intelligence / Profile preview

Levofloxacin Dosage in Bacterial Conjunctivitis

NCT00565123Phase 3Completed

Start
Sep 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of levofloxacin in bacterial conjunctivitis (BC). Started Sep 2004; status: completed.

02

Drugs

levofloxacin
03

Conditions

bacterial conjunctivitis (BC)

Beyond the preview

Go deeper on NCT00565123.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00565123.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call